Biologic agents for psoriasis treatment include tumour necrosis factor α (TNF-α) inhibitors, interleukin (IL)-23 inhibitors, IL-12/23 inhibitors, or IL-17 inhibitors [46]. Here, TNF is linked to psoriasis.